A self-assembling nanoparticle: Implications for the development of thermostable vaccine candidates.

International Journal of Biological Macromolecules
Ze-Hui LiuFang He

Abstract

Effective controls on viral infections rely on the continuous development in vaccine technology. Nanoparticle (NP) antigens are highly immunogenic based on their unique physicochemical properties, making them molecular scaffolds to present soluble vaccine antigens. Here, viral targets (113-354 aas) were genetically fused to N terminal of mi3, a protein that self-assembles into nanoparticles composed of 60 subunits. With transmission electron microscopy, it was confirmed that target-mi3 fusion proteins which have insertions of up to 354 aas in N terminal form intact NPs. Moreover, viral targets are surface-displayed on NPs as indicated in dynamic light scattering. NPs exhibit perfect stability after long-term storage at room temperature. Moreover, SP-E2-mi3 NPs enhance antigen uptake and maturation in dendritic cells (DCs) via up-regulating marker molecules and immunostimulatory cytokines. Importantly, in a mouse model, SP-E2-mi3 nanovaccines against Classical swine fever virus (CSFV) remarkably improved CSFV-specific neutralizing antibodies (NAbs) and cellular immunity related cytokines (IFN-γ and IL-4) as compared to monomeric E2. Specially, improved NAb response with more than tenfold increase in NAb titer against both CSFV S...Continue Reading

References

Jan 1, 1997·Annual Review of Immunology·M F Bachmann, R M Zinkernagel
Aug 3, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jayanth PanyamVinod Labhasetwar
Sep 25, 2003·The Journal of Experimental Biology·Susanna J Dunachie, Adrian V S Hill
Oct 2, 2003·Nature Biotechnology·Shuguang Zhang
Sep 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·K E Drexler
Mar 10, 2007·Current Molecular Medicine·Gary T Jennings, Martin F Bachmann
Jun 5, 2007·Expert Review of Vaccines·Bryce Chackerian
Feb 6, 2008·Current Opinion in Immunology·Sven Burgdorf, Christian Kurts
Oct 28, 2008·Biological Chemistry·Gary T Jennings, Martin F Bachmann
Oct 16, 2010·Nature Reviews. Immunology·Martin F Bachmann, Gary T Jennings
Jul 21, 2011·Journal of Drug Delivery·Aiala SalvadorJosé Luis Pedraz
Jun 19, 2012·Veterinary Immunology and Immunopathology·Elisa CrisciMaría Montoya
Jul 26, 2012·Nature Reviews. Immunology·Nils Lycke
Oct 12, 2012·The AAPS Journal·Vijaya B JoshiAliasger K Salem
Mar 28, 2013·Frontiers in Cellular and Infection Microbiology·Anthony E GregoryDiane Williamson
Jul 26, 2013·Nature Reviews. Immunology·Douglas M SmithJames R Baker
Feb 11, 2014·Carbohydrate Polymers·Pingli LiFengshan Wang
Dec 23, 2014·Nanomedicine·Mariusz Skwarczynski, Istvan Toth
Oct 3, 2015·Current Topics in Microbiology and Immunology·Jianying Yang, Michael Reth
Dec 23, 2015·Vaccine·Kimia KardaniSepideh Shahbazi
Feb 11, 2016·Computational and Structural Biotechnology Journal·Jacinto López-SagasetaMatthew J Bottomley
Oct 26, 2016·Biochemical Pharmacology·Christopher P Karch, Peter Burkhard
Apr 4, 2017·Current Opinion in Biotechnology·Bernd H A Rehm
Apr 25, 2017·Viral Immunology·Taiki Aoshi
May 20, 2017·Biotechnology Advances·Manica NegahdaripourYounes Ghasemi
Jul 22, 2018·ACS Nano·Theodora U J BruunMark Howarth
Jul 25, 2018·Frontiers in Cellular and Infection Microbiology·Dongliang WangYi Yang
Jan 30, 2019·Annual Review of Medicine·Barney S GrahamJason S McLellan
Feb 2, 2019·International Journal of Molecular Sciences·Huimei RenGuojun Zheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.